Dapagliflozin effect on cardiopulmonary function in HFrEF patients

M Mapelli, I Mattavelli, C Vignati… - European Journal of …, 2024 - academic.oup.com
Background Sodium-glucose co-transporter-2 inhibitors (SGLT2i) are currently a standard
therapy for patients with heart failure with reduced ejection fraction (HFrEF). This study aims …
相关文章

Dapagliflozin effect on cardiopulmonary function in HFrEF patients

M Mapelli, I Mattavelli, C Vignati… - European Journal of …, 2024 - academic.oup.com
Background Sodium-glucose co-transporter-2 inhibitors (SGLT2i) are currently a standard
therapy for patients with heart failure with reduced ejection fraction (HFrEF). This study aims …